ResMed Inc (NYSE:RMD) — Market Cap & Net Worth
Market Cap & Net Worth: ResMed Inc (RMD)
ResMed Inc (NYSE:RMD) has a market capitalization of $27.91 Billion ($27.91 Billion) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #961 globally and #410 in its home market, demonstrating a 0.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ResMed Inc's stock price $193.94 by its total outstanding shares 145056384 (145.06 Million). Review debt load of ResMed Inc to assess the company's total debt and financial obligations.
ResMed Inc Market Cap History: 2015 to 2026
ResMed Inc's market capitalization history from 2015 to 2026. Data shows growth from $6.98 Billion to $28.13 Billion (13.21% CAGR).
Index Memberships
ResMed Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$62.23 Trillion | 0.07% | #299 of 503 |
Weight: ResMed Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ResMed Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ResMed Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.79x
ResMed Inc's market cap is 6.79 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.94x
ResMed Inc's market cap is 24.94 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $8.24 Billion | $1.84 Billion | $352.41 Million | 4.48x | 23.39x |
| 2017 | $11.46 Billion | $2.07 Billion | $342.28 Million | 5.55x | 33.49x |
| 2018 | $15.63 Billion | $2.34 Billion | $315.59 Million | 6.68x | 49.53x |
| 2019 | $21.55 Billion | $2.61 Billion | $404.59 Million | 8.27x | 53.26x |
| 2020 | $29.81 Billion | $2.96 Billion | $621.67 Million | 10.08x | 47.95x |
| 2021 | $36.78 Billion | $3.20 Billion | $474.50 Million | 11.51x | 77.52x |
| 2022 | $29.62 Billion | $3.58 Billion | $779.44 Million | 8.28x | 38.01x |
| 2023 | $24.72 Billion | $4.22 Billion | $897.56 Million | 5.85x | 27.54x |
| 2024 | $33.17 Billion | $4.69 Billion | $1.02 Billion | 7.08x | 32.49x |
| 2025 | $34.94 Billion | $5.15 Billion | $1.40 Billion | 6.79x | 24.94x |
Competitor Companies of RMD by Market Capitalization
Companies near ResMed Inc in the global market cap rankings as of June 17, 2026.
Key companies related to ResMed Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #161 globally with a market cap of $147.71 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #255 globally with a market cap of $99.36 Billion USD ( €84.99 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #345 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #541 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #161 | Intuitive Surgical Inc | NASDAQ:ISRG | $147.71 Billion | $417.07 |
| #255 | EssilorLuxottica S. A. | PA:EL | $99.36 Billion | €183.55 |
| #345 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.00 |
| #541 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
ResMed Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, ResMed Inc's market cap moved from $6.98 Billion to $ 28.13 Billion, with a yearly change of 13.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $28.13 Billion | -19.48% |
| 2025 | $34.94 Billion | +5.33% |
| 2024 | $33.17 Billion | +34.18% |
| 2023 | $24.72 Billion | -16.55% |
| 2022 | $29.62 Billion | -19.47% |
| 2021 | $36.78 Billion | +23.41% |
| 2020 | $29.81 Billion | +38.33% |
| 2019 | $21.55 Billion | +37.85% |
| 2018 | $15.63 Billion | +36.38% |
| 2017 | $11.46 Billion | +39.06% |
| 2016 | $8.24 Billion | +18.01% |
| 2015 | $6.98 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of ResMed Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.91 Billion USD |
| MoneyControl | $27.91 Billion USD |
| MarketWatch | $27.91 Billion USD |
| marketcap.company | $27.91 Billion USD |
| Reuters | $27.91 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more